Exploration and validation of a combined immune and metabolism gene signature for prognosis prediction of colorectal cancer

Abstract excerpt

Background Colorectal cancer (CRC) is still one of the most frequently diagnosed malignancy around the world. The complex etiology and high heterogeneity of CRC necessitates the identification of new reliable signature to identify different tumor prognosis, which may help more precise understanding of the molecular properties of CRC and identify the appropriate treatment for CRC patients. In this study, we aimed...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Ferroptosis and cancer prognosis
• Share to Immune cells in cancer
• Share to Inflammation biomarkers and pathways